<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>mobihealthnews&#187; pharmaceuticals</title>
	<atom:link href="http://mobihealthnews.com/tag/pharmaceuticals/feed/" rel="self" type="application/rss+xml" />
	<link>http://mobihealthnews.com</link>
	<description>mobihealthnews - the daily mHealth industry monitor.  Subscribe for our free weekly e-newsletter!</description>
	<lastBuildDate>Thu, 29 Jul 2010 11:31:16 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Novartis invests $24M in Proteus Biomedical</title>
		<link>http://mobihealthnews.com/6013/novartis-invests-24m-in-proteus-biomedical/</link>
		<comments>http://mobihealthnews.com/6013/novartis-invests-24m-in-proteus-biomedical/#comments</comments>
		<pubDate>Tue, 12 Jan 2010 13:47:42 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[cardiovascular]]></category>
		<category><![CDATA[Diovan]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[organ transplantation]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<category><![CDATA[Proteus Biomedical]]></category>
		<category><![CDATA[psychiatric]]></category>
		<category><![CDATA[tuberculosis]]></category>
		<category><![CDATA[venture capital]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=6013</guid>
		<description><![CDATA[Pharmaceutical giant Novartis announced that would invest $24M in upfront cash and equity as part of an exclusive worldwide agreement for the pharma company to license Proteus Biomedical&#8217;s sensing technology for organ transplantation. (That must be the kind of exclusive deal Novartis had in mind when the two companies announced their collaboration on a pilot [...]]]></description>
		<wfw:commentRss>http://js-kit.com/rss/mobihealthnews.com/p=6013</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Roche inks deal with sleep monitoring start-up</title>
		<link>http://mobihealthnews.com/5215/roche-inks-deal-with-sleep-monitoring-start-up/</link>
		<comments>http://mobihealthnews.com/5215/roche-inks-deal-with-sleep-monitoring-start-up/#comments</comments>
		<pubDate>Mon, 02 Nov 2009 10:00:45 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[adverse effects]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[drug safety]]></category>
		<category><![CDATA[NeuroVigil]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<category><![CDATA[Roche]]></category>
		<category><![CDATA[TEDMED]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=5215</guid>
		<description><![CDATA[As we hinted last week, Wireless sensor and neuropathology start-up NeuroVigil has inked a deal with Swiss pharamceutical company Roche. NeuroVigil will provide Roche with its iBrain wireless sensors to help the company collect and analyze data during its clinical trials. NeuroVigil technology will be used to help the company&#8217;s development of various drugs for [...]]]></description>
		<wfw:commentRss>http://js-kit.com/rss/mobihealthnews.com/p=5215</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Novartis, Proteus pilot to lead to exclusive deal?</title>
		<link>http://mobihealthnews.com/4513/novartis-proteus-pilot-to-lead-to-exclusive-deal/</link>
		<comments>http://mobihealthnews.com/4513/novartis-proteus-pilot-to-lead-to-exclusive-deal/#comments</comments>
		<pubDate>Tue, 22 Sep 2009 22:45:58 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[intelligent medicine]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<category><![CDATA[Proteus Biomedical]]></category>
		<category><![CDATA[wireless remote monitoring]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=4513</guid>
		<description><![CDATA[
Pharmaceutical giant Novartis has tapped intelligent medicine start-up Proteus Biomedical for a small 20 patient study to track patients&#8217; compliance with their blood pressure drug regimen. The patients are taking blood pressure drug Diovan and the study organizers track their compliance via Proteus&#8217; &#8220;chip in the pill&#8221; technology, which reports to a receiver sensor on [...]]]></description>
		<wfw:commentRss>http://js-kit.com/rss/mobihealthnews.com/p=4513</wfw:commentRss>
		<slash:comments>13</slash:comments>
		</item>
	</channel>
</rss>
